Results oriented international diplomatic CPA/MBA-finance executive with extensive SEC, SOX, GAAP, IFRS, FP&A, M&A, IPO, ERP, IR, HR, cost, treasury, tax and supply chain experience. Enterprise value creator with a customer focus. Strategic and tactical problem solver. Partner, Leader, Educator.
FINANCE LEADERSHIP FOR THE ENTERPRISE
Highly experienced and accomplished Finance and Accounting leader with a record of achievement managing the finances of companies in Pharma, BioPharma, and Technology with annual revenues over $13 billion and market capitalization as large as $14 billion. A Strategic Partner and Trusted Advisor to CEOs and the Board of Directors adept in stewarding budgets and P&Ls as large as $50 million. A problem-solver who thinks strategically and acts tactically.
Well versed in balance sheet, cash management, risk management, and Sarbanes Oxley compliance as well as treasury and tax matters including planning and compliance, contract negotiations, financial regulatory matters, long range plans, lease negotiations, human resource, payroll and benefits including salary negotiations and compensation planning.
A history of advancement through increasingly responsible leadership roles including Director of Corporate Accounting, Chief Financial Officer, and Secretary. Operationally savvy and practiced in the management of key business functions including Accounting, Finance, Information Technology, Pharma Supply Chain Management, Facilities Management, and Human Resource Management. Recognized as a hands-on manager with exceptional team building skills.
Public Offerings " Joint Ventures " P&Ls " Project Management " Strategic Planning " Team Leadership & Motivation " Budgeting " Financial Analysis " Financial Statements " M&A " Reporting
Consulting and Holding Company 2011 Present
An accounting and management consulting firm specializing in assisting small technology companies in accounting and financial matters including USGAAP reporting, finance functional matters, including compliance, regulatory, contractual and strategic concerns. The responsibilities of which include, marketing, sales, customer service, management, finance, human resources, training, etc. while maintaining a high skill set level in the areas of communication, problem-solving, organization, management and computer applications.
Specialty Pharmaceuticals Company 2006 2010
A pharmaceutical development stage company with three products in phase III development.
Chief Financial Officer and Secretary
Served as Partner and Trusted Advisor to two successive CEOs and the Board of Directors. Responsible for all financial matters while positioning the company to bring a key product to market and to deliver value to shareholders through its sale to a large pharmaceutical company. Closely managed the efforts of professionals in Accounting, Finance, Information Technology, Pharma Supply Chain Management, Facilities Management, and Human Resource Management. Partnered with the CEO and VP of BD on all business development negotiations. Chaired the Joint Steering Committee on licensing.
Stewarded P&Ls and budgets as large as $45M. Guided capital raises in public and private markets. Led and managed all public SEC filings including interfacing with financial analysts, shareholders, and investment banks. Controlled General and Administration spending ranging from $4M to $8M per annum.
§ Funding Project - Played a pivotal role in funding ongoing company operations. Spearheaded the raising of over $76M in public and private capital placements while taking the lead in managing relations with investment banks, attorneys, auditors, and over 5,000 investors and potential investors.
§ Enabled the Company to position itself for $55.5M in potential earnings in out-licensing its lead product in Europe while driving $11M in cash for upfront milestone and inventory.
§ Avoided a security market collapse in late 2007. Liquidated more than $11M in auction rate securities well in advance of the world-wide financial collapse.
§ M & A Project (Sale of the business) Assisted the CEO in leading the marketing and sale of the Company by leading discussions at the Board level, developing marketing material used by the investment bank, developing and maintaining relationships with prospective buyers and orchestrating the sale of the Company to a large pharmaceutical company for more than $170M.
§ SEC Compliance Project - Ensured timely SOX compliance in a highly regulated industry. Achieved SOX compliance in only 6 months through accelerated filing and efficient project stewardship. Maintained compliance for 4 years running with no material weaknesses or significant deficiencies.
§ Listed the Company on the NYSE American Stock Exchange (AMEX).
§ Enterprise Software Implementation Project Lead the implementation and adoption of Oracle 11i as the enterprise business and financial software platform of choice. The complete company-wide adoption occurred in a matter of weeks.
Large Biopharmaceutical Company 1998 2006
One of the oldest biopharmaceutical companies in the US with over $4B in revenues and $14B in market capitalization.
Director of Corporate Accounting
Fueled the development of a world-class accounting function with turnover well below industry standards. Orchestrated the efforts of 21 accountants supporting external reporting, technical accounting, research and development, manufacturing, sales, general and administrative and the information technology functions. Provided high level direction in budgeting, forecasting, and latest estimate and P&L reporting as well as all financial reporting, worldwide closing and global consolidations. Served as senior liaison to the SEC while leading the development of all accounting policies and procedures as well as the adoption around the globe.
§ Cycle Time Project - Provided the CEO and CFO with an early view of anticipated revenue and earnings while enabling a significant reduction in closing cycle time. This was a worldwide project including over 25 different entities. Personally developed and managed the latest estimate process worldwide.
§ Business Development Project - Enabled the Company to achieve recognized revenues of $700M. Partnered with the business development group to develop an innovative commercial partnership model.
§ Mentoring Project - Led the development of the Finance Mentoring Program which played a pivotal role in establishing a corporate wide mentoring program delivered by Human Resources.
§ Compliance Project lead the enterprise wide adoption of Sox 302 and 404 across business units and statutory entities including the cross functional hierarchy of management.
Large High Technology Company 1996 1998
A leading computer manufacturer with market capitalization at the time of the acquisition was approximately $10B.
External Reporting Manager
Drove the preparation of public financial reports, including 10Qs, 10Ks, and earnings reports while providing accounting insight and oversight across more than 5 business units with $13 billion in revenues. Advised BU management on all accounting matters, new accounting regulations, and accounting regulation interpretation. Ensured compliance while enabling management to better understand the impact of regulations on their respective business units.
§ Pension and Retiree Healthcare Project - Earned management accolades as recipient of the 1998 CFO Award. Gained recognition of more than $160M for pension and retiree healthcare modifications over a 2-year period.
§ M & A Project (business unit divestiture) - Provided critical accounting contributions to a $150M spinoff of the companys Educational Services business unit. Delivered accounting and business consulting to the buyers during a 6-month transition period.
§ External Reporting Project - Assisted in the merger of two of the largest high tech firms at the time and worked for 8 months to ensure a methodical transition. This included working as the External Reporting Manager for the Combined Company and leading the filing of all SEC related documents, 8Ks, 10Qs, 10Ks, etc.
Medium Size Engineering Company, Accounting Supervisor 1993 1996
Small Pharmaceutical Company, Sr. Accountant 1991 1993
National Audit Firm, Audit Senior 1990
Large Regional Audit Firm, Audit Senior 1987 1989
MBA, Concentration in Finance, Sawyer School of Management; Suffolk University, Boston, MA
BS, Business Administration and Accounting, Salem State College, Salem, MA
Past Member of the American Institute of Certified Public Accountants
Past Member of the Massachusetts Society of Certified Public Accountants, Past board member of the Business and Industry subcommittee of the Massachusetts Society of Certified Public Accountants
Massachusetts Army National Guard (Hon), Troop A 1-26th Armored Cavalry Squadron
United States Navy (Hon), USS San Diego (AFS-6), USS Damato (DD-871), SIMA Little Creek
Oracle 11i; JD Edwards; McCormick & Dodge; Deltek; Quickbooks; Hyperion; Cognos; MS Word, Excel, Powerpoint, Visio, Outlook, Publisher, Access, MapPoint; CCH; Lexis/Nexis; Bloomberg